We are live on ! Find out more
FMS icon

Fresenius Medical Care

189 hedge funds and large institutions have $774M invested in Fresenius Medical Care in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 61 increasing their positions, 50 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 21

22% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 50

11% more capital invested

Capital invested by funds: $697M → $774M (+$77.1M)

2% more funds holding

Funds holding: 186189 (+3)

0.17% less ownership

Funds ownership: 5.38%5.21% (-0.17%)

96% less call options, than puts

Call options by funds: $4K | Put options by funds: $101K

Holders
189
Holders Change
+3
Holders Change %
+1.61%
% of All Funds
4.71%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
61
Reduced
50
Closed
21
Calls
$4K
Puts
$101K
Net Calls
-$97K
Net Calls Change
-$97K
Name Holding Trade Value Shares
Change
Change in
Stake
HL
1
Harding Loevner
New Jersey
$181M +$10.1M +219,213 +6%
CI
2
Cambiar Investors
Colorado
$125M +$3.69M +80,064 +3%
Bank of America
3
Bank of America
North Carolina
$68.3M -$3.68M -79,810 -5%
Northern Trust
4
Northern Trust
Illinois
$45.1M -$304K -6,594 -0.7%
Morgan Stanley
5
Morgan Stanley
New York
$33.9M -$427K -9,266 -1%
MAMU
6
Marathon Asset Management (UK)
United Kingdom
$30.5M -$170K -3,702 -0.6%
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$24.2M +$1.39M +30,119 +6%
US Bancorp
8
US Bancorp
Minnesota
$20.6M +$1.85M +40,121 +10%
PPA
9
Parametric Portfolio Associates
Washington
$19.1M +$1.22M +26,553 +7%
JFL
10
Jarislowsky, Fraser Ltd
Quebec, Canada
$14.1M -$73.9K -1,605 -0.5%
Wells Fargo
11
Wells Fargo
California
$12.7M -$424K -9,214 -3%
Goldman Sachs
12
Goldman Sachs
New York
$11.1M +$1.14M +24,705 +12%
AG
13
Aperio Group
California
$9.55M +$474K +10,302 +6%
State Farm Mutual Automobile Insurance
14
State Farm Mutual Automobile Insurance
Illinois
$8.73M
Invesco
15
Invesco
Georgia
$8.25M -$352K -7,648 -4%
TIM
16
Thornburg Investment Management
New Mexico
$7.77M +$509K +11,052 +7%
MNA
17
Manning & Napier Advisors
New York
$7.47M -$5.79M -125,700 -45%
Envestnet Asset Management
18
Envestnet Asset Management
Illinois
$6.96M +$135K +2,936 +2%
FWCM
19
Ferguson Wellman Capital Management
Oregon
$6.83M +$36.8K +800 +0.6%
Boston Partners
20
Boston Partners
Massachusetts
$6.18M -$576K -12,511 -9%
First Trust Advisors
21
First Trust Advisors
Illinois
$5.18M -$256K -5,567 -5%
Truist Financial
22
Truist Financial
North Carolina
$5.04M -$84.4K -1,832 -2%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$4.73M +$261K +5,662 +6%
William Blair Investment Management
24
William Blair Investment Management
Illinois
$4.24M -$372K -8,077 -8%
JP Morgan Chase
25
JP Morgan Chase
New York
$4.21M -$375K -8,138 -9%

FMS Hedge Fund Activity: Q2 2017 in Review

189 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q2 2017, worth a combined $774M — up 11% from $697M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new FMS positions and 21 closed out — a net gain of 5 holders — while 61 added to existing stakes and 50 trimmed.

The largest buyer was Harding Loevner, adding an estimated $10.1M. The largest seller was Millennium Management, cutting an estimated $11.4M.

  • 189 institutional investors held Fresenius Medical Care (FMS) as of Q2 2017, up from 186 in Q1 2017.
  • Funds reported $774M of Fresenius Medical Care stock for Q2 2017, up 11% quarter-over-quarter.
  • 26 funds opened new Fresenius Medical Care positions in Q2 2017 and 21 closed out, a net change of +5 holders.
  • The largest Fresenius Medical Care buyer in Q2 2017 was Harding Loevner, an estimated $10.1M added.
  • The largest Fresenius Medical Care seller in Q2 2017 was Millennium Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q2 2017.